Author:
Thoenes Alexandra,Cariolato Luca,Spierings Julian,Pinçon Alexis
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Duke J, Friedlin J, Ryan P. A quantitative analysis of adverse events and “overwarning” in drug labeling. Arch Int Med. 2011;171:941–54.
2. European Medicines Agency. Scientific guidelines with SmPC recommendations, rev 4, 25 January 2017. London: EMA; 2017.
3. King JP, Davis TC, Bailey SC, Jacobson KL, Hedlund LA, Di Francesco L, Parker RM, Wolf MS. Developing consumer-centered, nonprescription drug labeling. Am J Prev Med. 2016;40:593–8.
4. Kircik L, Sung JC, Stein-Gold L, Goldenberg G. United States Food and Drug Administration product label changes. J Clin Aesthet Dermatol. 2016;9:39.
5. Marcussen M. Branded versus generic label alignment: assessing safety and compliance in the US. PharmacoVigilance Rev 2016;9(1):6–10.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献